Company Description
CHINA INFRASTRUCTURE CONSTRUCTI (OTC: CHNC) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $5.0M.
CHNC stock has declined 60.0% over the past year.
This page provides a comprehensive overview of CHNC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CHINA INFRASTRUCTURE CONSTRUCTI (CHNC) stock. Over the past 12 months, the stock has lost 60.0%. At a market capitalization of $5.0M, CHNC is classified as a micro-cap stock with approximately 10.1B shares outstanding.
Latest News
CHINA INFRASTRUCTURE CONSTRUCTI has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include management, earnings. View all CHNC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CHNC Company Profile & Sector Positioning
CHINA INFRASTRUCTURE CONSTRUCTI (CHNC) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CHNC often look at related companies in the same sector, including (CADMF), Vencanna Ventures (TPPRF), (CADMD), (ATNX), and (CANBD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHNC's relative position within its industry.